[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Bloch et al., 2007 - Google Patents

T‐Cell inactivation and immunosuppressive activity induced by HIV gp41 via novel interacting motif

Bloch et al., 2007

View PDF @Full View
Document ID
6534066598656453383
Author
Bloch I
Quintana F
Gerber D
Cohen T
Cohen I
Shai Y
Publication year
Publication venue
The FASEB Journal

External Links

Snippet

Fusion peptide (FP) of the HIV gp41 molecule inserts into the T cell membrane during virus‐ cell fusion. FP also blocks the TCR/CD3 interaction needed for antigen‐triggered T cell activation. Here we used in vitro (fluorescence and immunoprecipitation), in vivo (T cell …
Continue reading at faseb.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Bloch et al. T‐Cell inactivation and immunosuppressive activity induced by HIV gp41 via novel interacting motif
Quintana et al. HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation
Raghuraman et al. Melittin: a membrane-active peptide with diverse functions
Müller-Eberhard The killer molecule of complement
TWI341844B (en) Hiv fusion inhibitor peptides with improved biological properties
Wexler‐Cohen et al. Demonstrating the C‐terminal boundary of the HIV 1 fusion conformation in a dynamic ongoing fusion process and implication for fusion inhibition
US20090270312A1 (en) Hiv-i gp41 fusion peptides for immunomodulaltion
Gerber et al. D‐enantiomer peptide of the TCRa transmembrane domain inhibits T‐cell activation in vitro and in vivo
Curicio‐Vonlanthen et al. Molecular parameters in melittin immunogenicity
JP2003519668A (en) Mapping of individual ATP-binding domains by inducing CTL in vivo without CD4 + T cells by heat shock protein fusion protein
US10377800B2 (en) Myelin oligodendrocyte glycoprotein (MOG) peptide
JP2009508937A (en) Diastereomeric peptides for modulating T cell immunity
Faingold et al. A GxxxG-like motif within HIV-1 fusion peptide is critical to its immunosuppressant activity, structure, and interaction with the transmembrane domain of the T-cell receptor
US8986712B2 (en) Peptides derived from HIV-1 gp41 transmembrane domain for t-immunomodulation
US20150175666A1 (en) Peptides derived from hiv gp41 for treating t-cell mediated pathologies
Chen et al. Identification and characterization of a T cell-inducing epitope of bovine ribonuclease that can be restricted by multiple class II molecules.
Cohen et al. Characterization of the interacting domain of the HIV-1 fusion peptide with the transmembrane domain of the T-cell receptor
Mano et al. Interaction of S413‐PV cell penetrating peptide with model membranes: relevance to peptide translocation across biological membranes
JP3699112B2 (en) Therapeutic compounds
Klug et al. The HIV gp41 pocket binding domain enables C-terminal heptad repeat transition from mediating membrane fusion to immune modulation
Faingold et al. An immunomodulating motif of the HIV-1 fusion protein is chirality-independent: implications for its mode of action
Boyer et al. Functional degeneracy of residues in a T cell peptide epitope contributes to its recognition by different T cell hybridomas
JP2001502897A (en) Cytotoxic peptide
EP2852609A1 (en) Coagulation factor viii with reduced immunogenicity
CZ20023586A3 (en) Identification of isolated potential immunodominant acetylcholine receptor alpha subunit peptides